Amid concerns that roughly half of the clinical trials in the U.K. are not publicly reported, a government official agreed to take steps to improve reporting and transparency, but stopped short of committing funds to implement recommendations made by a Parliamentary committee.
In a statement issued late last week, the government agreed to create a new portal for registering trials either independently or through the European Union; bolster requirements for universities to register studies; urge National Health Service Foundation Trusts, which are nonprofit entities that provide health services, to publish results; and propose a timeline for sponsors to disclose study results.
About the Author Reprints
